This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Ken
Director of Investor Relations
Good morning, and thank you for joining us on our first quarter earnings conference call. On the call today, Ed Tilley, our chairman, president, and CEO will discuss our performance for the quarter and provide an update on our strategic initiatives. Then, Brian Scheller, executive vice president, CFO, and treasurer will provide an overview of our financial results for the quarter, as well as an update on our 2022 financial outlook. Following their comments, we will open the call to Q&A. Also joining us for Q&A will be Chris Isaacson, our chief operating officer. John Dieters, our Chief Strategy Officer, and Dave Howson, President of CBOE Europe and Asia Pacific. I would like to point out that this presentation will include the use of slides. We will be showing the slides and providing commentary on each. A downloadable copy of the slide presentation is available in the investor relations portion of our website. During our remarks, we will make some forward-looking statements. Each represents our current judgment on what the future may hold. And while we believe these judgments are reasonable, these forward-looking statements are not guarantees of and uncertainties. Actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Please refer to our filing with the SEC for a full discussion on the factors that may affect any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, after this conference call. During the call this morning, we will be referring to non-GAAP measures as defined and reconciled in our earnings materials. Now, I'd like to turn the call over to Ed.
Ed Tilley
Chairman, President, and CEO
Thank you, Ken. Good morning, and thanks for joining us today. I'm pleased to report on strong financial results for the first quarter 2022 at CBO Global Markets, reflecting the continued strength of our business. During the quarter, year over year, we grew net revenue 14% to a record $418 million, and adjusted diluted earnings per share grew by 13% to a record $1.73 million. Our solid first quarter results were driven by the ongoing expansion and diversification of our business, with strong trading activity in our cash equity business. engaged with our product suite to manage risk. Average daily volume increased 42% in SVX options year-over-year, with fixed options increasing slightly year-over-year and up 18% over the fourth quarter of 2021. Multi-listed options trading, ADV, increased 2% year-over-year to a new record of 11 million contracts per day. Additionally, our European equities segment had a very strong quarter. Net revenue increased These results were driven by not just favorable market backdrop, but by the expansion of our data and analytics services to help clients improve the quality of their executions and enhance their overall trading experience across our lit and dark order books, periodic auctions, and SIBO Bids Europe. On the U.S. equity side, we were pleased to launch periodic auctions on our BYP European periodic auctions offering. Turning to Asia-Pacific, SIPO Japan market share increased considerably during the first quarter to 3.8%, up from 2.9% in the fourth quarter of 2021, as a result of new liquidity provider program designed to attract new volume to the market. We are excited to have a growing footprint in Japan, which is the fourth largest equities market in the world by volume traded. In Australia, volumes remain strong across our equities business, and we are also preparing to list Asia Pacific's first crypto ETFs on SIBO Australia in the coming weeks. We're excited to be helping to bring these innovative products to market. Importantly, while achieving strong results, we continue to successfully execute on key initiatives to advance our corporate strategy to innovate, integrate, and grow our business globally. In February... we completed the migration of MatchNow, the largest equities alternative trading system in Canada, to SIBO Technology, creating a unified trading experience for all of our North American customers. Along with this technology migration, we launched SIBO Bids Canada, bringing a new and enhanced block trading offering to the Canadian equities market. It's important to note that these enhancements SIBO Bids Canada sponsors. We look forward to further expanding our footprint in Canadian equities market with the expected close of our acquisition of NEO later this quarter, subject to regulatory approvals and customary closing conditions. We also announced plans to migrate SIBO Australia to our world-class technology platform in February 2023, pending regulatory review and approval. We appreciate the early engagement with customers in Australia on this important initiative, and we will be working closely with them throughout the year as they make their preparations for the migration. As we continue to broaden and evolve SIBO, our global network gives us the unmatched ability to efficiently scale and expand our business in new ways, both organically and inorganically. As we architect the business for future growth, the appointment of David Housen to President of SIBO on May 12. Many of you know Dave well, as he currently serves as President of our European and Asia-Pacific segments, and has done a remarkable job working with the team and our customers to successfully grow these businesses. His track record speaks volumes, and he has spearheaded the development and execution of some of SIBO's most innovative products and services. Dave is planning to relocate from London to Chicago and will oversee SIBO's business lines globally. Please welcome Dave as he joins us on the call today. I believe the enhancements to our management team showcase our deep bench of talent and position SIBO well to advance our global expansion strategy. As mentioned last quarter, we are focused on executing on the transformational opportunities we see in three core areas of our business. Data and access solutions, Civo Digital. We continue to fuel these opportunities by executing against our ongoing strategy, which remains consistent. Leverage our superior technology, further strengthen our core proprietary products, increase recurring revenue, and expand our product line by geography and asset class. During the first quarter, we made solid progress advancing each of these core areas of our business. Let me begin with data and access solutions. This growth was driven by continued demand for access to our exchanges, proprietary market data, and new subscribers to SIBO's front-end platforms. SIBO Global Cloud, a cloud-based market data streaming service we launched during the fourth quarter, continues to gain traction with customers. This new service aims to increase access to our unique data set to customers globally. via the cloud. We continue to believe this business is positioned incredibly well moving forward. Given our competence, we are increasing our 2022 targeted organic growth rate for data and access solutions to 8% to 11% from 7% to 10%. Our unique product set, coupled with our geographic and asset class diversification, enables us to meet the needs of customers from London the ongoing challenges of the pandemic. Market participants have increasingly turned to derivatives and volatility vehicles to help mitigate risk. We continue to innovate and expand our derivatives business Earlier, I noted our overall strong volumes across our proprietary products franchise, as we continue to see solid momentum trading in SPX and VIX options since launching 24-5 trading in November 2021. During the first quarter, average daily volume in SPX options during global trading hours increased 164% year-over-year, more than double the volume prior to launch of 24-5. Although still in its early days, the incremental volume we are seeing as a result of 24-5 enhancements has already generated an attractive return on our 2021 investment. Last week, we added Tuesday expirations to our SPX weeklies complex and plan to add Thursday expirations beginning May 11th. These new listings build on the success of our SPX. total SVX options volume as they allow investors to manage their short-term U.S. equity market exposure and execute trading strategies with even greater frequency, precision, and flexibility. We have received very positive feedback from a broad range of market participants and we are off to a strong start. On Tuesday, we saw over 600,000 Tuesday expiry contracts traded. Last month, we were excited to launch with initial volumes which have topped 3,500 contracts on several days and we plan to continue to expand the network of retail brokers offering this product. We expect this market to continue to flourish over time and we look forward to engaging with this growing retail segment. Turning now to Europe, our European derivatives business continues to gain momentum and we are pleased Earlier this week, we launched features and options on four additional country indices, Italy, Spain, Sweden, and Norway. This second phase of products broadens our equity index product suite to cover additional key European markets, providing customers with the tools to efficiently manage their European index exposures via a single marketplace. The expansion of our global derivatives franchise is laying risk. Turning now to Cibo Digital and our planned acquisition of ARIS X, which remains on track to close very soon, subject to customary closing conditions. ARIS X will provide Cibo with spot trading, data, and clearing capabilities for digital assets and derivatives trading, clearing, and data through its regulated futures exchange and clearinghouse. This is a pivotal moment for Cibo as we re-enter the digital asset assets. As we said before, we believe CBO can play a guiding role in shaping the trajectory of this revolutionary market. We have been actively engaged with regulators as they shape policy for this emerging asset class. Additionally, the ARIS-X application for margin futures is currently in review at the CFTC. We look forward to welcoming the ARIS-X team to CBO and accomplishing great things together as CBO Digital. We are focused on driving durable and I will turn over to Brian.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Thanks, Ed, and good morning everyone. Let me remind everyone that unless specifically noted, my comments relate to 1Q22 as compared to 1Q21 and are based on our non-GAAP adjusted results. As Ed discussed, the year is off to a very strong as both the transaction and non-transaction elements of our business perform well. We believe these strong results validate our investment focus as we continue to put capital to work across our ecosystem to help us enable to take full advantage of the favorable market dynamics. Quickly touching on some of the noteworthy takeaways from the first quarter, our net revenue led by the strength in our derivatives markets and data and access solutions categories. I would like to note the change in our income statement to reflect cash and spot markets, data and access solutions, and derivatives markets categories we laid out at the November Investor Day. The update reflects how we think about the business in addition to our segments and how we will be reporting our results moving forward. You can find more details in our 10-Q. Noting a couple highlights for our updated categories in the first quarter, derivatives markets produced 18% year-over-year organic net revenue growth in the first quarter, given the strength of our index business. Data and access solutions net revenues were also up 18%, up 12% on an organic basis, helped by strong new subscription and unit growth. And cash and spot markets produced 5% net revenue growth for the quarter, up 2% on an organic basis, on the back of strong volumes and market share in our European cash equities business. Please note that historical quarterly values for these categories covering the 2020 and 2021 timeframes are available on our IR site. Adjusted operating expenses increased 17% to $146 million. Adjusted EBITDA of $281 million was up 12%. And last, results. Turning to the key drivers by segment, our press release and the appendix of our slide deck includes information detailing the key metrics for each of our business segments. So I'll just provide some summary thoughts. We saw impressive year-over-year growth in many of our segments during the quarter. index options. Total options ADV was up 6% as our higher margin index options volumes increased 27% over 1Q21 levels. RPC moved higher by 18% giving a continued positive mix shift to index products and a stronger mix of higher price STX options in our index business. And lastly, we continue to benefit from another quarter of of 2021. North American equities net revenue decreased by 3% year-over-year against some difficult comparisons to the first quarter of 2021. Industry volumes were lowered by 12% and market share declined by 70 basis points versus the first quarter of 2021. On a sequential basis market share improved by a full percentage point and industry ADV was up nearly 20%. On the non-transaction quarter of 2021. The Europe and APAC segment again delivered outsized growth for the quarter with net revenue of 37%. The increase was driven by higher volumes and the inclusion of SIBO Asia-Pacific revenues of $8.4 million. Net transaction fee growth of 47%. Outpaced solid clearing fee growth of 10%. Transaction fees volume growth and a 5 percentage point increase in market share. Clearing fees benefited from an increase in clearing volumes of 52%. First quarter revenue increased 2% in the futures segment as transaction and non-transaction revenues posted slight gains for the quarter. Volumes and rate for contract metrics quarter of 2021. And finally, revenues in the FX segment were up 16% as compared to the first quarter of 2021. Net transactions and clearing fees benefited from a 13% increase in average daily notion of value traded and a slight increase in net capture rates. As noted previously, SIBO's data and access solutions revenue growth 90% of the year-over-year revenue increase, as opposed to pricing changes. More specifically, we saw robust physical and logical port usage in our options and equities businesses, driven by increased demand for trading capacity. And on the market data side, the equities top-of-book and options depth-of-book products continued to perform well. As we look to 2022, we see tremendous potential for the data and access solutions business. We are raising our targeted DA Investor Day. Turning to expenses. Total adjusted operating expenses were approximately $146 million for the quarter, up 17% compared to last year. Excluding the impact of acquisitions owed less than a year, adjusted operating expenses were up 12% or $15 million for the quarter. Moving to our expense guidance, we are reaffirming our full year expense guidance range of $617 to $625 million for 2022 As we have previously stated, we expect our expense base to build over the course of this year as we invest behind many attractive initiatives at CBOE. We expect $23 to $26 million of the 2022 investment spend to directly drive incremental revenue growth. We believe that approximately $10 million is needed for infrastructure enhancements to support and scale our business for greater levels of activity in the future. In the past, we have talked to investments in areas like DNA, or our Euro-CCP acquisition and integration as producing solid returns for SIBO. I would like to point out that a few of our more recent 2021 investments are already producing some very attractive returns as well. For instance, 24x5, which went live in November, has translated to year-to-date global trading hour volumes in the SPX first quarter. Tuesday expirations went live last week, and this Tuesday we saw over 600,000 Tuesday expiring contracts traded, a very strong start. We recognize that each of the investments we make across our ecosystem is unique, with different return profiles, payback periods, and levels of complexity. In each case, though, we leverage the same core attributes that make CBOE CBOE, the ability to leverage our superior technology across cycles, from short-term initiatives like 24x5 to longer-term endeavors like the EuroCCP acquisition, EU derivatives launch, introduction of bids block trading capabilities in new equities markets, and other multi-year integration and technology migration activities. Looking ahead to our pending acquisitions, we expect to close the ARIS X transaction very soon, subject to customary closing conditions, and anticipate a mid-year closing for NEO, also subject to regulatory review and other customary closing conditions. Adjusting our prior expense framework for the updated timings, we expect the acquisitions of ARIS X and NEO to add an incremental $30 to $35 million to our 2022 guided range of $617 to $625 million. We continue to anticipate that revenues from ARIS X and NEO will offset more than half of the expenses in 2022. the additions are evened out positive on a combined basis in year two. The company plans to further refine its guidance for 2022 after the acquisitions close. Now turning to a summary of full year guidance on the next slide, given our early year performance and positive outlooks for the businesses, we are providing incrementally positive updates for the many elements we spoke to at our investor day back in November. Specifically, as we have already mentioned, we now anticipate DNA organic net revenue growth will be in the 8% to 11% range, up from the previous guidance of 7% to 10%. Acquisitions held less than a year have performed well, and we are slightly increasing our guidance, calling for acquisitions held less than a year to contribute between 2% and 3% to total net revenue growth in 2022, up from our prior guidance of 1% to 3% points. And our overall organic net revenue growth target remains unchanged after the first quarter at 5% to 7% for 2022. But we see potential upside to our revenue expectations given the early performance of our growth initiatives and the year-to-date macro trading environment. Depreciation amortization is expected to be in the $40 million to $44 million range. and we continue to anticipate our effective tax rate on adjusted earnings to be in the 27.5% to 29.5% range for 2022 under the current tax laws. Our interest expense for the first quarter of 2022 was $10.8 million. Given the incremental borrowing costs related to the financing put in place, million for 2Q22. On the capital front, our focus has been and remains maximizing shareholder value through the effective use of our capital. In the first quarter, we returned a total of $121 million to shareholders, comprised of $51 million in dividend payments and $70 million in share repurchases. We remain well positioned to invest in the business. remaining capacity on our share repurchase authorization. Our leverage ratio increased versus the prior quarter to 1.6 times at March 31st, as our debt levels increased with issuance of a 10-year note in anticipation of our NEO and ARISX transactions. Overall, we remain committed to maintaining a flexible balance sheet and putting capital to work in the most value-enhancing way possible for shareholders. In summary, SIBO kicked off 2022 on very strong footing
Ed Tilley
Chairman, President, and CEO
Thanks, Brian. In closing, I would like to thank our team for the incredible progress made throughout the first quarter. 2022 is off to an exceptional start, and with the help of our dedicated associates, we are well positioned to define markets globally, delivering value to our customers and shareholders.
Ken
Director of Investor Relations
At this time, we'd be happy to take your questions. We ask that you please limit your questions to one per person to allow time to get to everyone. Feel free to get back in the queue, and if time permits, we'll take a second question.
Operator
Conference Call Operator
Thank you. As mentioned, at this time, we will begin the question-and-answer session. To ask a question, you may press star, then 1 on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To try your question, please press star, then 2. At this time, we will pause momentarily to assemble the roster. And the first question comes from Rich Rapetto with Sandler O'Neill.
Rich Rapetto
Analyst at Sandler O'Neill
Good morning, Ed and Brian and Chris. So I guess my question is on the proprietary products and the VIX futures volume. You've seen a rebound since sort of the mid-quarter, first quarter slowdown. I guess that's due to the Barclays, the VXX ETF issuance issue. But I guess could you give us an update? you know, on the recovery in the VIX futures and more broadly in the proprietary product volumes. Like you talked a lot about index options, you see great growth. And can you give us a picture of what's happening, what's in your control, what you think is volatility driven?
Ed Tilley
Chairman, President, and CEO
Cool. Thanks, Rich. Big question there and a really good one. A lot of it at the heart of it, really the macro trading, what's going on more macroly. But Brian, why don't we start and just
Brian Scheller
Executive Vice President, CFO, and Treasurer
Rich, as we look at that, and you did point that out as far as the timing, as far as mid-March goes with the Barclays announcement, and just, again, to make sure we're all on the same page, is that they've cited themselves that they intend to file a new automatic self-registration statement with the SEC as soon as practical, and they remain committed to structured products and business in the U.S. So we've seen that. There's no reason for us to believe that's likely to be the case. Obviously, in the interim, we've also seen New funds come into that space as well from an ETM perspective.
Ed Tilley
Chairman, President, and CEO
Thanks, Brian. So, Rich, maybe if we look at what's in our control, what's not under control is a good way to look at the volumes. So they are solid across asset class, and we are in a sustained level of higher volatility if we use the historic level of VIX. And it's really the macro knowns being the key drivers. You know, interest rates rising, inflation, the war in Ukraine, supply chain as a result of the continued COVID issues primarily in China, all not in our control. The mix of our products continue to be driven primarily by the relationship of implied versus realized volatility. Very similar story to what we talked about last quarter. When implied vols are below realized volatility, Our users are buying optionality and exposure and protection cheaper than the underlying is moving. So long gammas paying off with large interday moves. Again, not in our control. Customers continue to be very active around short-dated options and optionality that they provide. Again, this is customer-driven. We're watching what they trade, not in our control. So what is it that we can control? Well, it's design, it's development, and the extension of access to the complex. trading. And with that access comes certainty and confidence in our platform with round-the-clock access to liquidity. So we added 24.5 for SPX and VIX options. We've been sharing with you again the amount of interest in super short-dated options. So we added Tuesday options and soon to add Thursday. We added a curb session. We're almost done in launching our new design trading for to global liquidity. And we launched a contract designed for retail in the nano contract, which provides access to the S&P 500. So in our control is really expansion and access and listening. And that's, I guess, the punchline. Thanks for that question, Reg.
Rich Rapetto
Analyst at Sandler O'Neill
Got it. That's very helpful. I was going to ask about the conservative expense guidance, but that's old. Thanks.
Ed Tilley
Chairman, President, and CEO
Wow. We'll let you get back in the queue, Rich.
Rich Rapetto
Analyst at Sandler O'Neill
I'm sure someone else will ask.
Operator
Conference Call Operator
Okay, thank you. And the next question comes from Don Fanon with Jefferies.
Don Fanon
Analyst at Jefferies
Thanks. Good morning. Wanted to follow up on the access and data strength and the improved guidance. So you talked about increased demand for capacity, but curious about the incremental customer, the type of customer, and maybe what you're seeing on the retail side, if you've really tapped into what that opportunity could be in terms of incremental demand.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Sure. I'll take that. Sorry, Dan. Sorry, Dan. As we think about all the elements of the DNA growth, and I really want to touch on all, it's not direct retail per se, but retail can be behind a lot of those trends as far as where we're seeing that data hit. the cash and spot markets to the derivatives markets. So it's underlying that as a part of that, but we don't see that directly coming in per se. But it is certainly driving some of that transaction volume and certainly driving that real-time data and that real-time access. So as far as where those customers, we look at where that new growth is and we look at that composition of that new revenue, we're actually seeing the largest part coming outside of North America. About 42% we saw was North America, and the rest was EMEA and APAC, which we love those numbers because it's hitting the growth of where we are today, but it's also highlighting the, we think, more significant upside of it's still barely scratching the geography and what we can do there. And we're really excited when we think about the incremental cloud offerings that we have coming online, and we think about the incremental risk and market analytics information that we're seeing that we're putting together and where that growth is coming from, both a mix of new as well as incremental share of wallet. So, again, we continue to be very excited about where that is and those offerings, again, across the globe.
Don Fanon
Analyst at Jefferies
Thank you.
Operator
Conference Call Operator
Thank you. And the next question comes from Gonzalo with Credit Suisse.
Gonzalo
Analyst at Credit Suisse
Thank you. Good morning. Thank you for taking my question. Can you please speak to the extent that SIBO European derivatives is easing structural challenges and market fragmentation that slowed European options volume growth? And also, given the initial momentum of that business, Is there upside to the 25 million euro revenue growth by 2024 outlook?
Ed Tilley
Chairman, President, and CEO
Dave Howes, and welcome to the call.
Dave Howson
President of CBOE Europe and Asia Pacific
Thanks very much, and thanks very much for a great question. Certainly, in terms of the summary of the value proposition and the – macro factors that are in place or were in place two years ago when our customers came to us with the idea and the opportunity of breaking into and really growing the European equity derivatives market. We looked at that fragmentation, the siloing across Europe. We looked at the need for a single-stop shop and also that need for an on-screen lit liquid market very much in line with what we enjoy, all of our customers enjoy in the U.S. And with the acquisition of EuroCCP, we were able to bring that all together with a single trading, single margin pool, across country benchmarks and pan-European benchmarks. So really giving that single access point there with increased efficiency through products designed from the ground up. And those products based off indices that are based off our equities market prices. And as you heard in the In the prepared remarks, the European equities market share has grown 500 basis points over the last year, so really solidifying the products that trade on those venues. So what we've seen since launch last year is a continuation of that commitment from the initial round of customers, with Q1 being four times the size in terms of trading from Q4 last year. The new products, We launched this week, have gone well with good support. Really crucially with those new products now we get to access different national benchmarks across Europe and therefore new local customers and new local expertise. So what you're going to see really from here on out is further build out of the futures picture across the products, the price picture there, followed by the options and also greater engagement as we look through to next year in the addition of single names. And really with the guide we've given on the revenues there, we're looking really on a good path there as we build out this product and this initiative. The size of the opportunity is still – the window between European and U.S. markets is still there, and we're really looking forward to going on building this out with our customers.
Gonzalo
Analyst at Credit Suisse
Got it. Thank you.
Operator
Conference Call Operator
Thank you. And the next question comes from Alex Cram with UBS.
Alex Cram
Analyst at UBS
Hey, good morning, everyone. You may have talked about this before, but just a quick one on the new initiatives on the proprietary products, the after-hours trading, the new weeklies. Can you just remind us what the pricing strategy is there right now? Are there any incentives that you're providing or how does pricing generally compare so we can have an idea of how they might flex your RPC as these businesses hopefully grow faster than your traditional offerings.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Yeah, there's no difference in pricing. I mean, so you won't see any mix from these products that you're seeing that's going to have any impact other than having a, for example, a higher mix of SPX contracts in our overall mix of options. But it's not going to be we're going to charge incrementally more during, let's say, that global trading hour session versus regular trading hour session.
Alex Cram
Analyst at UBS
Okay. And so there's never been a contemplation for, like, I think other markets when they have global access, usually those fees are a little bit higher, but not really something that you're contemplating or doing?
Brian Scheller
Executive Vice President, CFO, and Treasurer
No. We don't think it's that type of market build per se. Okay. You'll see that when we've launched other new products or new markets, for example, when we've done with European derivatives, there will be some, say, certain liquidity incentives in place or when we rolled out various, you know, call it IBOX futures. We will do that with the new products, but here it's a little bit of a different type of rollout here with the initiatives we've talked about here with SPX.
Alex Cram
Analyst at UBS
Fair enough. Thank you.
Operator
Conference Call Operator
Thank you. And the next question comes from Owen Lau with Oppenheimer.
Owen Lau
Analyst at Oppenheimer
Good morning, and thank you for taking my question. So on DNA, you started the year at 12% organic growth. You raised the guidance, but the growth is still higher than the high end of your guidance range, and you keep investing in this area. So what area may concern you that the growth may slow down for the rest of this year? And then additionally, when you continue to expand into Europe, How can DNA potentially benefit from that? I mean, if you can talk about the progress of offering your analytics products to your European clients, that would be great. Thank you.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Sure. I'll start with that. And it isn't so much of a slowdown for the progress that we see this year. We've got a pretty good view into our particular pipeline on the global indices work and the contracts we see on the queue there and the various initiatives that we have going. I would say if you look at, and it's kind of a silly answer, but if you look at the math of the comparisons that you see, how we ramped up 2021 growth in this area, if you look at, for example, the consecutive growth rates quarter over quarter in 21, you know, Q2 had a 2% growth rate over Q1. Again, I'm talking about 21 here. If you look at Q3, it actually had a 7% growth rate over the 2Q. And then you look at Q4. Then it had a 4% growth rate on top of that. So you see a continuous momentum build. We started out 21 with a run rate of an amount of $99 million per quarter, and we exited at $112 million. for the fourth quarter. So you can see that really nice ramp up. So as we see our growth, and we've been able to continue that ramp into Q1, and we do have some plans in place. So just more naturally, we're just going to see a little bit more flattening out of that higher growth rate as we move into Q2, Q3, and Q4 relative to the comparison of last year. And as you look at how we continue to create the winds across the globe, This goes back to the benefits of the flywheel, what we're doing, our global network. As we build out our people, as we build out the sales force, and as we continue to build out, I'll call it market share volumes, that continues to build off of each other going back to the long-term benefit of our flywheel of seeing how they interrelate. If you look at particularly the risk and market analytics, the biggest I mentioned earlier to a previous question was is that the growth we have had so far has been more of an increased share of wallet versus new customers. So we're really excited about bringing that offering to new geographies as we continue to add more sales capacity and capability to the different geographies that we are in. Got it.
Owen Lau
Analyst at Oppenheimer
Thank you very much.
Dave Howson
President of CBOE Europe and Asia Pacific
And certainly I can chime in there a little bit more on the European opportunity. It's multifold. Again, first principles, you've got the European market share, 21% market share offers richer, more deeper, a deeper data set to look into for local customers and global customers taking the European equities data. But moreover, it's the sale of the U.S. data set, the SIBO1 product sets that we've got, which provides a real opportunity into CFDs, CFD providers, retail providers in Europe and EMEA and Asia Pacific. And then when you also think about the RMA product set, SIBO Europe derivatives bases a lot of the theoretical options prices used off the Hanwick Theo options prices that we get there. So we see a lot of opportunity in Europe for providing that value add, pre-trade, at-trade and post-trade risk management and analytics services. And then as you think further eastwards, we can look at Australia and Japan, where we see strong non-transaction revenues coming out of the core venues there with, for example, Australia's non-transaction revenue increased over 30% compared to quarter one last year.
Owen Lau
Analyst at Oppenheimer
Got it. Thank you very much.
Operator
Conference Call Operator
Thank you. And the next question comes from Brian Bedell with Deutsche Bank.
Brian Bedell
Analyst at Deutsche Bank
Folks, maybe if I can sneak a two-parter in here, one for Brian and one for Dave. Brian, just on the revenue guidance, you did say in the comments in the release about there being potential upside to the revised revenue growth targets. Maybe can you just sort of whether that's something that would inch this guidance up every quarter potentially, and more importantly, is that more based on global macro market volatility or rather the performance of your growth initiatives? And then just one for Dave, on the European consolidated tape, just any kind of view on that? That's a project, obviously, that's been talked about for many, many years. would think SIBO is in the best position to offer that. Maybe any kind of initial thoughts on that and creating a more concentrated data solution for Europe.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Thanks. Good question. And I will just, again, continue to reiterate that if the macro environment does stay the same, you know, there's a lot of confidence that we will exceed that 5% to 7% organic, you know, net revenue growth rate, targeted growth rate. And what you'll see in this environment is not only due to the comps, particularly with the strong first quarter last year and the various asset classes, is that you actually see a positive growth across all of our asset classes over the prior year, which is going to really contribute. And again, most strongly we saw that in the index and the options. So really the honest answer to your question is it kind of depends as far as the quarter, as far as the full year and how we inch that up as we continue. 24 by 5. We're excited about the very, very, very early Tuesday, Thursday and what we see going on there. That's encouraging. So as we continue to see that traction, if things continue to go well, could there be an inch up of guidance in 2Q next time we have this call? Certainly. And we'd have, obviously, a better visibility in the full year as far as the really strong traction we're seeing with those organic initiatives and then continuing views of the macroenvironment.
Dave Howson
President of CBOE Europe and Asia Pacific
Absolutely. You're spot on there. We are emphatic supporters of a consolidated take and its introduction into the European environment. We strongly believe in a single investable, tradable pan-European environment, as well as a UK market now post-Brexit. We think this will give palpable and real benefit to end investors. We've seen the benefits from the SIPs in the United States and certainly think investors deserve that in the European environment. Key aspects that I could go on for an hour, but I will save you that, are that we include pre-trade as well as post-trade in this consolidated tape and it be offered at a reasonable commercial basis with a good and fair revenue share model, much the way we see things operating in the United States. We, like many others, are placed well to be a consolidated tape provider, as you point out, because we do ingest much of the data globally and we also happen to run the largest trade reporting facility in Europe with about 85% market share there. So well-placed, but we're heavily engaged in the debate as things unfold with our customers and the policymakers. So we will keep the market updated with that as we progress.
Brian Bedell
Analyst at Deutsche Bank
That's great, Tyler. I appreciate it and welcome. Looking forward to hearing more comments on Europe and the firm in the future from you. Thanks, Dave. Thank you. Thank you.
Operator
Conference Call Operator
And the next question comes from Kyle Voigt with KBW.
Kyle Voigt
Analyst at KBW
Hi, good morning. So you mentioned that 90% of the growth in data and access is really driven by additional subscriptions and these incremental units. Just given there's been some heightened investor focus on retail traders maybe beginning to disengage a bit from the highs we saw last year, Just curious, if we were to see a meaningful pullback in kind of industry volumes across your key markets, do you think that we'd see demand for ports or new units kind of slow meaningfully from the current levels, or has this been driven by more secular or other trends? Thanks.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Yeah, I would say it's primarily for – I'd say it's probably a mix of both. It's hard sometimes to disentangle the two. I can tell you what we've seen more historically. When we continue to look at this question and actually as we put together this forecast and this guidance, we knew there are some elements of that port revenue that is a bit volume driven. We also know it's maintaining capacity for future periods that rarely do we see people pull back on the level of ports. particularly when we know that when investors and when our clients, when they're in these markets, how they make money, they tend to make money in those highest volumes, those highest peaks, those highest volatility at a time. And not having that capacity is critical to their overall P&L. So rarely do we see them pull back on some of that. Now, there's a couple of pricing dynamics where some of that volume – They pull back a little bit of that, but like I said, we tend to see that as more broadly infrastructure. And the other base of, I'll call it revenues that we're building within DNA, are beyond just obviously the real-time and access in the risk and market analytics and the overall indices that we continue to build out, which frankly, those are actually, while the smallest parts of our overall DNA mix, they are the highest growth. hopefully play out over time. But back to your original question, the heart of it is it's a little bit of both, but we see it historically have been pretty sticky.
Chris Isaacson
Chief Operating Officer
And I'll just mention there as well, we rarely see port counts come down or unit counts come down as the messaging traffic across our markets continues to grow regardless of retail engagement or not as that may ever flow. Messaging volumes continue to go To go north, that's the direction they've gone for decades, really. I'll just mention as well, you know, DNA robustness, or we think a lack of risk, even as retail engagement may overflow, is that they tend to use less messaging traffic, which is really where the capacity is focused. And so the market-making community, the other institutions, there's been a cycling into institutional volume with the higher volatilities. We expect to see demand very, very strong across our products and our markets for access and data. And I'll mention as well, again, Siebel Global Cloud, we're really getting after a new user there in different jurisdictions, but using the data across our network. So we think that's durable also.
Kyle Voigt
Analyst at KBW
Great. Thank you very much.
Operator
Conference Call Operator
Thank you. And the next question goes to Michael Cypress with Morgan Stanley.
Michael Cypress
Hi, good morning. This is Stephanie on for Mike. I just have a follow-up about the progress you've made around 24-5. Just curious if you view the next steps as moving towards 24-7. What are your thoughts around that, and what trends or data points will you be watching to give you confidence if you were to extend to 24-7?
Ed Tilley
Chairman, President, and CEO
Well, Chris, you can handle, I think, the technology aspect of that. I think really when we look to expansion on access, really primarily been in the institutional side and we know that there's growing interest around the clock access as retail base grows as well so we think we've got the right product set and then there's a readiness from our introducing brokers on whether or not to provide access to customers so that debate going on not just at SIBO's level I would say that we've proven that we are ready from a technology perspective, but really accommodating our customers is key. Again, back to my opening remarks, this is about listening and delivering on demand. But, Chris, as far as any further expansion on the clock?
Chris Isaacson
Chief Operating Officer
Yeah, absolutely. Stephanie, it's a great question. We're a customer-driven company here. As customers bring us demand for products, for access to markets. We'll listen to that demand and provide it. 24.5 is a great example of that. Even the curb session launched this week. I will remind you, as we look forward to closing the transaction for ARIS X, that already trades 24 by 7. I'll also mention that we're expanding our index platform from 24.5 to 24.7 this year. That's part of one of our strategic projects under Kathy Clay and the DNA team. As our customers and the investing community wants more access, more around the clock, we'll provide that when the demand's there.
Michael Cypress
Great. Thank you.
Operator
Conference Call Operator
Thank you. And the next question comes from Alex Blotstein with Goldman Sachs.
Stephanie
Representative for Michael Cypress, Morgan Stanley
Hey, good morning. Thanks, everybody, for taking the question. So I was hoping to dig into Aris X&E a little bit more. I guess first, an easy one, maybe just kind of walk us through the sources of lower expenses that you guys expect from both of those for the rest of the year. And then more importantly, bigger picture, as you're thinking about integrating these assets over the next two years, can you provide us with a roadmap of sort of sources of revenues to getting these kind of products into profitability? So sort of like what's kind of the low hanging fruit over the near term and what needs to go really well for you guys to potentially meet or exceed expectations? A great question.
Ed Tilley
Chairman, President, and CEO
Why don't we start, Brian, the ARISX and NEO effect on expenses. Chris, the ARISX likely closing before NEO in the very soon category, and then we can move on to NEO.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Yeah. The good questions as far as, and we could, to use one of Dave's earlier lines, we could go on hours as far as what our plans are for growth for these, but I'll try to be brief here is, we've laid out in our guidance as far as what we expect the expense impact to be to obviously our P&L for this year and then I'll call it that EBITDA contribution when you roll that in. And so that's been more about it's not so much an expense story as that continuing to grow the revenues and particularly around the digital side and I'll let Chris talk a little And then around NEO and with respect to that has a wonderful growth trajectory and what we're seeing year-over-year growth similar to what Dave mentioned in the SIBO Japan, SIBO Australia and what that has done for us organically even post-acquisition. own P&L. So we see NEO playing a very important role as far as growing the revenue synergies within what we're doing around our existing Canadian operations, our broadly North American operations around that listings franchise. And with that, I think I'll turn it back to Chris for ARIS.
Chris Isaacson
Chief Operating Officer
Yeah, Alex, we're really excited about closing this transaction very soon. I want to remind you that with the one transaction, We get spot trading platform data, derivatives, and clearing. And as you think about the opportunities for revenue there as we scale it and, you know, work through the syndication with industry partners. Spot trading, we're looking to add new coin listings as soon as we can. We talk about data. We have to build the spot platform, and there can be data that comes off of that. Margin futures, we have a margin futures application before the CFTC. that's focused on FCMs, so we look forward to growing that. Derivatives business, I think clearing is maybe something that's not as focused on, but a real key asset that we get with ARISX as we think there may be some bilateral relationships that maybe some of those trades can be cleared over time. It's a real asset for us to grow there, so there could be clearing revenues also. So very excited about this transaction and deeply engaged also in the digital asset regulation conversation right now that's very active. We want to help lead that discussion with many others and help this new asset class grow and mature in a great way so we can operate these markets in trusted, regulated, transparent ways we do the rest of our markets. With that, I think I'll hand it to Dave to cover NEO.
Dave Howson
President of CBOE Europe and Asia Pacific
Yeah, great. Thanks, Chris. And as a reminder, of course, we already have a foothold in Canada with MatchNow and Enjoyed the migration in February to SIBO technology and the introduction of SIBO Bids Canada, really opening up the bids network there to Canadian investors and to investors around the world to invest in Canada and vice versa. So with NEO, super excited about a number of things. The different trading mechanisms that NEO brings to the party as we consolidate our place in the Canadian competitive landscape. Those different trading protocols really bring a new diverse customer set to the existing set we welcome to match now today. So there's the trading mechanisms. Then there's listings. Listings, NEO has 121 ETFs and 56 corporates, a couple of debentures and those Canadian depository receipts. A great level of innovation already there. And really that gives us a great blueprint to think about how we can expand our listings offerings around the world. We've got over 640 ETPs already, but then how do we think about our listings strategy on top of that global securities network that we've been able to build out? Low-hanging fruit, SIBO 1 Canada is the data product we'll be bringing out. So the additional, the additive effect of Canadian data, including those unique listings that NEO enjoys, onto our data products, and then later on those data products into the cloud. So you see the repeating patterns here. So really looking forward to getting going with the NEO team as we progress towards a close, which is going according to plan.
Stephanie
Representative for Michael Cypress, Morgan Stanley
Great. Very helpful.
Dave Howson
President of CBOE Europe and Asia Pacific
Thank you.
Operator
Conference Call Operator
Thank you. And the next question was a follow-up with Alice Cram with UBS.
Alex Cram
Analyst at UBS
Hey, thanks again. Sorry for dragging out the call. Just one quick follow-up on all the data and access questions earlier. You don't disclose, I don't think, retention rates like many of the other data companies in the space do. So can you maybe just give us an update on where retention is and how that's been trending? And when it comes to cancellations, maybe what customer types or products you're seeing the biggest cancellations and why? Thanks.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Alex, we don't – I think we can look to potentially enhance that disclosure as far as looking at – as far as where we are. But right now, I will tell you just as a very, very high level is that some of the growth that we've seen – and we indicated this last year on our call and when we saw some of the higher growth rate – is that we've actually seen fewer cancellations than what we had traditionally modeled. So we have to think it's a fairly positive story, and we've been more focused on the I would call it new and ads, and we've seen fewer cancellations than we've seen historically. We call it, you know, pre-pandemic. So positive trends there, but, again, we'll look for that at disclosures. Again, we like to evaluate metrics and items that can enhance, I'll call it, the investor information.
Alex Cram
Analyst at UBS
Interesting. Do you know where you're seeing the biggest cancels, just so we have an idea? I know it seems to be very small, but just curious where there's the most turnover in the book of business, I guess.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Yeah, no, I think we'll just – I'll defer and wait until I have the firm data there from the team.
Alex Cram
Analyst at UBS
Sounds good. The color was helpful. Thank you.
Brian Scheller
Executive Vice President, CFO, and Treasurer
Sure.
Operator
Conference Call Operator
Thank you. And that was the last question. I would like to return the floor to management for any closing comments.
Ken
Director of Investor Relations
Great. So that completes our call for today. Thank you so much for your time and interest in the company. Thank you.
Operator
Conference Call Operator
Thank you. The conference has now concluded. Thank you for attending today's presentation. We now disconnect your lines.
Disclaimer